2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of thePoint-of-Care Glucose Testing Market?

The point-of-care glucose testing market is predicted to expand due to the increasing instances of diabetes. This chronic metabolic affliction elevates blood sugar levels, culminating over the years in severe harm to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is an often utilized method for determining glucose levels in hospitalized patients. It expedites treatment decisions in response to glucose level variations, increasing the effectiveness of treatment and the management of diabetes. For instance, The National Health Service (NHS England), a UK public healthcare entity, reported in June 2024 that the individuals recognized by NHS in England as pre-diabetic had increased to 3,615,330 in 2023 – an 18% jump from 3,065,825 in 2022. Furthermore, there was a roughly 25% increase in cases among individuals below 40, escalating from 173,166 in 2022 to 216,440 in 2023. Therefore, the mounting prevalence of diabetes is fueling the growth of the point-of-care glucose testing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

How Will the Growth Rate of thePoint-of-Care Glucose Testing Market Impact Industry Trends by 2034?

The market size for point-of-care glucose testing has been consistently expanding over the recent years. A growth from $4.91 billion in 2024 to $5.15 billion in 2025 is anticipated, reflecting a compound annual growth rate (CAGR) of 4.9%. This growth, witnessed in the historical span, is fueled by factors like escalating diabetes prevalence, increased consciousness regarding diabetes management, a growing elderly population, expansion of healthcare infrastructure and widespread uptake of point-of-care testing.

The point-of-care glucose testing market is set for a robust expansion in the upcoming years, primed to reach $6.51 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This growth trajectory for the forecast period can be traced back to factors like the rise of telemedicine, an increasing focus on individualized diabetes care, upswing in diabetes management programs, surge in investment for glucose testing research and development, and the adoption of continuous glucose monitoring. The forecasted period is also anticipated to observe trends such as the emergence of wearable glucose monitoring devices, the incorporation of smartphone capability into glucose testing, expanded use of point-of-care testing in domestic healthcare environments, application of artificial intelligence in analyzing glucose data and a broader implementation of remote patient scrutiny for diabetes.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

What Key Market Trends and Innovations Are Shaping the Future of thePoint-of-Care Glucose Testing Industry?

Product innovation is emerging as a prominent trend in the point-of-care glucose testing market, with key players aiming to introduce unique products to solidify their market stance. For instance, Switzerland-based healthcare giant F. Hoffmann-La Roche AG launched a new point-of-care blood glucose monitor named Cobas Pulse in January 2022, designed for healthcare workers. The device comes with a companion tool designed like a touchscreen smartphone which runs its own applications. The Cobas Pulse functions as a pocket-sized device with an automatic glucose test strip reader, camera, and touchscreen for recording diagnostic data. It features a durable case that can withstand disinfection, making it suitable for use with patients across various age groups, including newborns and those in intensive care. Moreover, it aims to streamline the workflow for medical practitioners by integrating Glucommander dosage software into the blood glucose reader. It also supports apps developed by companies like Smart4Diagnostics, CardioSignal, and SteadySense that can be downloaded for decision-making assistance.

Which Companies Are Leading the Charge in Expanding thePoint-of-Care Glucose Testing Market Growth?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

How is the Global Point-of-Care Glucose Testing Market Segemented?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Which Geographics are Influencing the Growth of the Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Point-of-Care Glucose Testing Maret 2025, By The Business Research Company:

Spray Drying Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Neurostimulation Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: